U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 3,981 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. Documentation of Heart Rate During Fluid Resuscitation for Children With Severe Sepsis or Septic Shock (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-fullreport.pdf
    June 01, 2018 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular … Severe sepsis includes sepsis plus one of the following clinical states: cardiovascular organ dysfunction … Septic shock is defined as sepsis and cardiovascular dysfunction (Goldstein, et al., 2005; Rivers, Ahrens … Shock occurs when the cardiovascular system is unable to provide energy resources (oxygen and glucose

  2. Timely Antibiotics for Children With Severe Sepsis or Septic Shock (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-fullreport.pdf
    April 02, 2018 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular … Severe sepsis includes sepsis plus one of the following clinical states: cardiovascular organ dysfunction … Septic shock is defined as sepsis and cardiovascular dysfunction (Goldstein, et al., 2005; Rivers, Ahrens … Shock occurs when the cardiovascular system is unable to provide energy resources (oxygen and glucose

  3. Maskedstats Nis 2018 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core_Weighted.PDF
    January 01, 2018 - PACEMAKER IMPLANT W/O CC/MCC 30,500 0.09% 245: AICD GENERATOR PROCEDURES 5,710 0.02% 246: PERCUTANEOUS CARDIOVASCULAR … 114,950 0.32% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 265,655 0.75% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 33,620 0.09% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 45,885 0.13% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 38,560 0.11% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 15,330 0.04% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W

  4. Maskedstats Nis 2018 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core.PDF
    January 01, 2018 - PACEMAKER IMPLANT W/O CC/MCC 6,100 0.09% 245: AICD GENERATOR PROCEDURES 1,142 0.02% 246: PERCUTANEOUS CARDIOVASCULAR … 22,990 0.32% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 53,131 0.75% 248: PERCUTANEOUS CARDIOVASCULAR … : AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 6,724 0.09% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 9,177 0.13% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 7,712 0.11% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 3,066 0.04% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W

  5. Maskedstats Nis 2019 Core Weighted V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
    January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 30,025 0.08% 245: AICD GENERATOR PROCEDURES 4,970 0.01% 246: PERCUTANEOUS CARDIOVASCULAR … 122,925 0.35% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 272,370 0.77% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 33,120 0.09% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 49,305 0.14% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 40,320 0.11% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 16,035 0.05% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W

  6. Maskedstats Nrd 2017 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core_Weighted.PDF
    January 01, 2017 - PERC CARDIOVASC PROC W DRUG-ELUTING STENT W MCC OR 4+ VESSELS/STENTS 78,895 0.22% 246: PERCUTANEOUS CARDIOVASCULAR … PERC CARDIOVASC PROC W NON-DRUG-ELUTING STENT W MCC OR 4+ VES/STENTS 7,943 0.02% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 36,039 0.10% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 41,389 0.12% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 37,885 0.11% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 16,924 0.05% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W

  7. Maskedstats Nrd 2018 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core_Weighted.PDF
    January 01, 2018 - PACEMAKER IMPLANT W/O CC/MCC 32,154 0.09% 245: AICD GENERATOR PROCEDURES 5,834 0.02% 246: PERCUTANEOUS CARDIOVASCULAR … 114,873 0.32% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 275,905 0.78% 248: PERCUTANEOUS CARDIOVASCULAR … AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 35,218 0.10% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 42,951 0.12% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 38,570 0.11% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 15,654 0.04% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W

  8. Kid 2019 Maskedstats Core Weighted V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
    January 01, 2019 - PACEMAKER IMPLANT W/O CC/MCC 137 0.00% 245: AICD GENERATOR PROCEDURES 116 0.00% 246: PERCUTANEOUS CARDIOVASCULAR … <= 50 *.**% 247: PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC <= 50 *.**% 248: PERCUTANEOUS CARDIOVASCULAR … 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MCC 847 0.01% 270: OTHER MAJOR CARDIOVASCULAR … PROCEDURES W MCC 2,776 0.05% 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 1,195 0.02% 272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 481 0.01% 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC

  9. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DCfAJZvNDzSYu7NqLJX2bv
    March 01, 2016 - significantly decreased risk of all-cause mortality (22% vs 25%; adjusted HR, 0.83; 95% CI, 0.73-0.95) and cardiovascular … AREDS, Age-Related Eye Disease Study; aRR, adjusted risk ratio; BCVA, best-corrected visual acuity; CV, cardiovascular … vitamin E58) and lung cancer in smokers (beta-carotene59,60) when prescribed for prevention of cancer or cardiovascular … Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled … Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.

  10. Comparative Effectiveness Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Aspirin and antiplatelet/anticoagulant agents Rofecoxib=35.3% Celecoxib=21.9% p<0.0001 (a) Cardiovascular … (n=19,087); rofecoxib 7/99- 9/99 (n=15,268) 270 NR NR Meloxicam NR Thromboembolic events: (A) cardiovascular … (AMI) between January 1, 1992 and October 31, 1997; ≤ 75 years of age; free of metabolic or cardiovascular … aged 50 years or younger ≥ 60 prior to event NR NR Other NSAIDs (excluding naproxen) NR Cardiovascular … solution qid 4 weeks 1-week washout for patients on NSAIDs Aspirin up to 325 mg/day for cardiovascular

  11. Nis 2006 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Severity.PDF
    January 01, 2006 - AMI, HEART FAILURE OR SHOCK 31107 0.39 173: OTHER VASCULAR PROCEDURES 52491 0.65 174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 55249 0.68 175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 138299 1.71 176: CARDIAC … PROCS WO CC 6094 0.08 1101: MAJOR CARDIOVASCULAR PROCS W CC 12493 0.15 1102: MAJOR CARDIOVASCULAR … System 289 0.00 CVS81: Neoplasm, Malignant, Cardiovascular 35 0.00 CVS82: Other Atherosclerosis 11940 … 0.15 CVS83: Other Cardiac Conditions 4213 0.05 CVS84: Other Cardiovascular Symptoms 122866 1.52 CVS85

  12. Nis 2004 Summarystats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_SEVERITY.PDF
    January 01, 2004 - AMI, HEART FAILURE OR SHOCK 29837 0.37 173: OTHER VASCULAR PROCEDURES 44133 0.55 174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 48919 0.61 175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 115875 1.45 176: CARDIAC … PROCS W CC 12033 0.15 1102: MAJOR CARDIOVASCULAR PROCS W MCC 7528 0.09 1130: AMPUT CIRC DISOR EXC … System 249 0.00 CVS81: Neoplasm, Malignant, Cardiovascular 39 0.00 CVS82: Other Atherosclerosis 11528 … 0.14 CVS83: Other Cardiac Conditions 3943 0.05 CVS84: Other Cardiovascular Symptoms 4019 0.05 CVS85

  13. Nis 2005 Summarystats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_SEVERITY.PDF
    January 01, 2005 - AMI, HEART FAILURE OR SHOCK 29739 0.37 173: OTHER VASCULAR PROCEDURES 44759 0.56 174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 49577 0.62 175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 117916 1.47 176: CARDIAC … PROCS W CC 11530 0.14 1102: MAJOR CARDIOVASCULAR PROCS W MCC 7570 0.09 1130: AMPUT CIRC DISOR EXC … System 272 0.00 CVS81: Neoplasm, Malignant, Cardiovascular 48 0.00 CVS82: Other Atherosclerosis 11074 … 0.14 CVS83: Other Cardiac Conditions 4000 0.05 CVS84: Other Cardiovascular Symptoms 3792 0.05 CVS85

  14. Nis 2003 Summarystats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_SEVERITY.PDF
    January 01, 2003 - AMI, HEART FAILURE OR SHOCK 28864 0.36 173: OTHER VASCULAR PROCEDURES 37169 0.47 174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 47984 0.60 175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 111697 1.40 176: CARDIAC … PROCS W/O CC 5293 0.07 1101: MAJOR CARDIOVASCULAR PROCS W CC 11277 0.14 1102: MAJOR CARDIOVASCULAR … System 261 0.00 CVS81: Neoplasm, Malignant, Cardiovascular 43 0.00 CVS82: Other Atherosclerosis 10706 … 0.13 CVS83: Other Cardiac Conditions 3922 0.05 CVS84: Other Cardiovascular Symptoms 4429 0.06 CVS85

  15. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
    October 01, 2010 - Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes … Meta- analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized … Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

  16. Archived: Evidence Summary: Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/carotid-artery-stenosis-screening-july-2014
    July 08, 2014 - study 78 that attempted to externally validate 2 tools using a cohort of 5449 participants from the Cardiovascular … The Cardiovascular Health Study. Stroke . 1998;29:2371-6. … Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular

  17. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
    October 01, 2010 - Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes … Meta- analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized … Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

  18. Final Progress Report: Developing an HIV-Specific Prevention Index Using the Electronic Medical Record (pdf file)

    www.ahrq.gov/sites/default/files/2025-02/meenan-report.pdf
    January 01, 2025 -  create opportunities for other conditions to emerge, such as non‐AIDS‐ related cancers, diabetes, cardiovascular … smears,  among other preventive services, and has been applied to clinical areas such as diabetes, cardiovascular … Explorations of quality of care in the management of diabetes, cardiovascular disease, and cancer, for

  19. Table 5.A.1. Evidence Table (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
    January 01, 2014 - Analgesics and narcotics, antibiotics, cardiovascular agents, and anticoagulants accounted for 31% … Operative AEs comprised 44.9% of the total AEs, while drugs, especially antibiotics and cardiovascular … of endotracheal tubes for all patients admitted to the ICU; (2) standardized handoffs from the cardiovascular

  20. Executive Summary: Implementing PCOR To Increase Referral, Enrollment, and Retention in Cardiac Rehabilitation through Automatic Referral with Care Coordination (pdf file)

    www.ahrq.gov/sites/default/files/publications2/files/takeheart-executive-summary.pdf
    August 01, 2023 - Million Hearts®, in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation … CR is a comprehensive secondary prevention program designed to improve cardiovascular health following … been shown to improve outcomes for patients with heart disease – reducing hospitalization and risk of cardiovascular
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (977)

psnet.ahrq.gov (864)

effectivehealthcare.ahrq.gov (685)

www.uspreventiveservicestaskforce.org (552)

hcup-us.ahrq.gov (442)

digital.ahrq.gov (340)

cds.ahrq.gov (60)

meps.ahrq.gov (30)

cdsic.ahrq.gov (13)

integrationacademy.ahrq.gov (12)

qualityindicators.ahrq.gov (3)

pso.ahrq.gov (2)

datatools.ahrq.gov (1)